From Local to Global: How Taiwan's Leading Biotech Firm is Fueling Its Global Expansion

With a strong presence in over 22 countries, MBI (Maxigen Biotech Inc.) is a prominent player in the medical device industry, specialising in innovative materials and solutions. Committed to quality and compliance, MBI ensures that its medical devices meet international standards. However, as the company expands its global reach, it faces unique challenges, particularly in managing the legal complexities of contracts across diverse jurisdictions.

Facing the Challenges of Multinational Operations 

The International Legal Affairs Department at MBI found itself grappling with the increasing demands of contract drafting, review, and regulatory research. With only three dedicated members managing both Chinese and English contracts, the workload often felt overwhelming. Jessica Chen, a senior legal specialist, recalls the struggles they faced:

"Before using Lexis+ AI, we relied on manual research and public databases like Google, which were time-consuming and often unreliable. Drafting contracts for different jurisdictions was particularly challenging, as each transaction model had to be discussed on a case-by-case basis and had to spend hours researching regulations."

A Turning Point for Legal Productivity

Recognising the need for a more efficient solution, MBI turned to Lexis+ AI, a generative AI tool specifically designed for legal professionals. This decision marked a significant turning point in their operations. The impact of Lexis+ AI was immediate. Jessica shared how the tool transformed their approach to contract drafting: 

"With Lexis+ AI, I can generate a complete contract draft in minutes. For example, I recently needed to create a supplemental agreement. I uploaded the original contract, explained the changes needed, and the AI generated a draft that I only had to fine-tune.”

Reliable Research at Their Fingertips

The accuracy of legal research became another game-changer for the team. Jessica noted,

"Unlike ChatGPT, which can’t guarantee the accuracy of its sources, Lexis+ AI is built on a trusted legal database. This gives us confidence in the information we use, whether it’s for contract drafting or regulatory compliance.”

The ability to summarise complex regulations and provide actionable insights proved invaluable to MBI's international operations.

Reclaiming Time for Strategic Initiatives

With routine tasks now automated, MBI’s legal team could shift their focus to higher-value projects. Jessica explained the significant time savings:

"Lexis+ AI has saved us 40% of the time we used to spend on contract drafting and30% on legal research. This has freed up our team to focus on strategic tasks, such as optimising contract terms and developing new compliance processes.”

A Ripple Effect on Collaboration and Response Times

The integration of Lexis+ AI created a positive ripple effect throughout MBI’s operations. The legal team’s ability to respond swiftly to contract requests enhanced collaboration with the overseas business department, leading to quicker deal closures and stronger client relationships.

Jessica emphasised the noticeable difference:

"Our colleagues have commented on how much faster we’re able to turn around contracts, which has been a huge win for our team and the company as a whole.”

A Partnership for Growth

For MBI, Lexis+ AI has evolved into more than a tool; it has become a strategic partner in enhancing efficiency, accuracy, and innovation within their legal operations. By automating routine tasks and providing reliable insights, Lexis+ AI has empowered MBI’s legal team to concentrate on initiatives that align with the company’s global ambitions.

As Jessica aptly summarised:

By streamlining their workflow with Lexis+ AI , MBI has saved up to 40% of the time previously spent on low-value tasks.

This efficiency allows them to focus on strategic initiatives, such as developing new compliance processes that could further enhance their global presence in the biotech sector.